Novel VTA from Oxigene markedly reduces tumor blood flow and exerts potent antitumor effects April 17, 2002
Late-breaking AACR presentation describes preclinical profile of new orally active mTOR inhibitor April 17, 2002
Hedgehog antagonist with potential in BCC identified at Curis using novel screening assays April 16, 2002
RSS